News Extra [these Stories Appear Only On The Web]

Drug company chairman calls for trial period to evaluate drugs

BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7223.1456e (Published 04 December 1999) Cite this as: BMJ 1999;319:1456
  1. Roger Dobson
  1. Abergavenny

    Demands that the pharmaceutical industry should show “value in use” at the time of a drug's launch are misguided, GlaxoWellcome's chairman, Sir Richard Sykes, warned this week. He suggested that a new way forward would be a system where drugs could be value tested while they were on the market for a …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe